Universitat Autonoma de Barcelona Researcher Updates Current Study Findings on COVID-19 (Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab)

Press/Media

Period30 Apr 2024

Media coverage

1

Media coverage

  • TitleUniversitat Autonoma de Barcelona Researcher Updates Current Study Findings on COVID-19 (Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab)
    Media name/outletNewsRx COVID-19 Daily
    Date30/04/24
    PersonsClaudia Guío-Sánchez